Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy
NCT02912520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2017-04-25
Summary
Investigators hypothesize that Immunoglobine (Ig) production is influenced by the microbiota of the gut. Investigators will compare microbiota-dependent Ig production in the bronchoalveolar lavage fluid of patients with and without antibiotic therapy in order to detect significant differences.
Conditions
- Immunoglobulin A
Interventions
- DRUG
-
Anti-Bacterial Agents
administration of any antibiotic substance(s) over the course of 2 weeks
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Oliver Robak, MD · Medical University of Vienna
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2017-04-23
- Completion
- 2017-04-23
Countries
- Austria
Study Locations
More Related Trials
-
Ethnic Differences in the Inflammatory Response in Systemic Inflammation
NCT00284869 ·Status: COMPLETED ·Phase: PHASE1
-
Innate Immune Response During Community Acquired Pneumonia
NCT03379207 ·Status: TERMINATED
-
Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections
NCT02171338 ·Status: UNKNOWN ·Phase: PHASE4
-
Development of an Atlas of Respiratory Host-microbiome Interactions in Healthy Volunteers
NCT06518161 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.
NCT01224977 ·Status: UNKNOWN ·Phase: NA
-
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
NCT01662258 ·Status: WITHDRAWN ·Phase: NA
-
The Association Mechanism Between the Microbiome and the Development of Community Pneumonia Was Studied Based on the Analysis of Pulmonary Microbiota - Host Interaction Network
NCT06896019 ·Status: ACTIVE_NOT_RECRUITING
-
Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study
NCT02557958 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
NCT05280132 ·Status: RECRUITING ·Phase: NA
-
A Trial of Procalcitonin in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT04682899 ·Status: UNKNOWN ·Phase: PHASE3
-
Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia
NCT00914550 ·Status: COMPLETED
-
Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)
NCT00132860 ·Status: UNKNOWN ·Phase: PHASE4
-
mNGS for Detection of Pathogens for Pulmonary Infection
NCT03798925 ·Status: UNKNOWN
-
Development a Method to Extract Antibiotic Concentration From Interstitial Lung and Epithelial Lining Fluid.
NCT03970265 ·Status: COMPLETED
-
Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter
NCT00688610 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Analysis of Infections by Spectrometry of Exhaled Breath
NCT03299608 ·Status: RECRUITING
-
A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis
NCT00042588 ·Status: COMPLETED ·Phase: PHASE2
-
CRP-guided Antibiotic Treatment in COPD Exacerbations Admitted to the Hospital
NCT01232140 ·Status: UNKNOWN ·Phase: NA
-
A Sputum Screening Test to Rule-out Pneumonia at an Early Stage
NCT03256604 ·Status: COMPLETED
-
DNA-based Testing in BAL of Lung Transplant Recipients With Suspected Non-viral Lower Respiratory Tract Infection
NCT02568358 ·Status: UNKNOWN
-
Evaluation of Inflammatory Cytokines During COVID-19
NCT04824495 ·Status: UNKNOWN
-
Microbiome Analysis of Skin and Airway Samples and Effect of Face Masks
NCT04894422 ·Status: UNKNOWN
-
Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation
NCT01109160 ·Status: COMPLETED ·Phase: PHASE4
-
Azithromycin in Bronchiolitis Obliterans Syndrome
NCT01009619 ·Status: COMPLETED ·Phase: PHASE4
-
Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy
NCT01819298 ·Status: COMPLETED